For more information or confidential assistance
800-306-3180
se habla español

Jury Agrees with Plaintiff Allegations in Risperdal Case

A Risperdal lawsuit that was pending in a Philadelphia court resulted in a mixed outcome for the plaintiff. The 19-year-old man filed the lawsuit against Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, claiming that the defendants’ medication resulted in the abnormal growth of breast tissue. On Friday, March 20, the... Read more »

Minnesota Mother Files Zofran Lawsuit Over Birth Defects

A mother of two young children has filed a Zofran lawsuit against GlaxoSmithKline (GSK) alleging that the anti-nausea medication led to both of her children’s serious health problems. The Minnesota mother filed her lawsuit on behalf of herself and her minor children in the U.S. District Court for the Eastern... Read more »

Axiron Lawsuit Filed Over Heart Attack Death

An Axiron lawsuit has been filed over a heart attack death that plaintiffs contend was caused by testosterone replacement therapy. The complaint, filed on March 17 in the U.S. District Court for the Northern District of Illinois, Eastern Division, names Janice Ollenburger, individually and on behalf of Jerry Ollenburger, the... Read more »

Bayer Faces Xarelto Class Action Lawsuit in Canada

In addition to a growing number of cases in the United States, Bayer now faces a Xarelto class action lawsuit in Canada. Plaintiff Betty Samson filed the complaint in Calgary and another is likely to follow in Ontario, where an elderly woman bled to death while taking the drug. The complaint includes... Read more »

New Study Explores Transplacental Transfer of Zofran

A recent study published in the medical journal Clinical Pharmacology & Therapeutics evaluated the possibility that the anti-nausea drug, Zofran (ondansetron) might be used to treat neonatal abstinence syndrome. In doing so, the researchers also assessed the possible transfer of the drug from mother to fetus via the placenta. Zofran... Read more »

Research Misconduct Involving Xarelto Goes Unreported

xarelto pill bottle
JAMA Internal Medicine recently published a study by Charles Seife that highlights a profound flaw in how consumers obtain information about clinical drug trials. According to the New York University professor, only 4 percent of questionable practices or violations discovered by health regulators during pharmaceutical trials ever reaches the public.... Read more »